Oct 28, 2020
Experience shows that, in response to pandemics, national governments tend to follow their own interests instead of pursuing a more globally coordinated approach. This nationalistic behaviour could have negative consequences on how well the COVID-19 global pandemic is managed and contained.
A situation in which countries push to get first access to a supply of vaccines, potentially hoarding key components for vaccine production, has been commonly referred to as 'vaccine nationalism'. This report examines how the management of the COVID-19 crisis may be affected by vaccine nationalism and what the associated economic cost would be of inequitable access to vaccines across countries.
Background: the COVID-19 crisis and a lack of global coordination and cooperation
Estimating the economic implications of vaccine nationalism
The macroeconomic modelling framework
Economic effects of inequitable access to COVID-19 vaccines by country (real annual GDP in $bn)